Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BHFAN vs BHFAM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BHFAM Captures Overall Composite Edge (33.6 SELL vs 33.7 SELL), While BHFAN Leads 1–0 on Growth & Valuation Pillars

BHFAM Overall Winner 6-Pillar Tally: BHFAN 1 – 0 BHFAM (5 Tie) Matrix Metrics: BHFAN 1 – 1 BHFAM

As of Nov 20, 2026, Brighthouse Financial, Inc. Depositary shares each representing a 1/1,000th Interest in a Share of 4.625% Non-Cumulative Preferred Stock, Series D (BHFAM) captures the overall head-to-head institutional edge over Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) on higher Unified Composite conviction (33.6/100 SELL vs. 33.7/100 SELL) after splitting the core matrix 1–1 (led by composite factor balance), while BHFAN wins 1–0 across the 6-pillar growth and valuation breakdown. BHFAN trades at $9.18 (N/M Forward P/E, 18.4% operating margin) versus BHFAM at $8.53 (N/M Forward P/E, 18.4% operating margin).

  • Growth vs. Quality Trade-Off: BHFAM earns the overall head-to-head edge with a stronger Unified Composite Score (33.6/100 SELL vs. BHFAN 33.7/100 SELL) and 0.47β · 22% Vol risk profile, whereas BHFAN leads top-line expansion (-52.7% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Defensive Composite Rating Caution: Although BHFAM compares more favorably head-to-head, both BHFAN (33.7/100 SELL) and BHFAM (33.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: BHFAN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9); meanwhile BHFAM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHFAN vs BHFAM
BHFAN NASDAQ
Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C
Life Insurance
$9.18
-0.65% 1D
Market Cap N/A
TTM Revenue $5.81B
Forward P/E N/M
Beta / 30D Vol 0.36β · 16% Vol
Unified Composite Score
33.7 / 100 SELL
Tech 18.0 Fund 37.0 Flow 50.0 Mom 49.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.0%), weak momentum, RSI 18
RSI-14: 17.9 · SMA20: $10.09 · SMA50: $10.65
BHFAM NASDAQ Head-to-Head Winner
Brighthouse Financial, Inc. Depositary shares each representing a 1/1,000th Interest in a Share of 4.625% Non-Cumulative Preferred Stock, Series D
Life Insurance
$8.53
-0.12% 1D
Market Cap N/A
TTM Revenue $5.81B
Forward P/E N/M
Beta / 30D Vol 0.47β · 22% Vol
Unified Composite Score
33.6 / 100 SELL
Tech 21.0 Fund 33.0 Flow 50.0 Mom 45.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 28
RSI-14: 27.5 · SMA20: $9.10 · SMA50: $9.48

6-Pillar Scorecard Institutional Category Breakdown (BHFAN 1 – 0 BHFAM)

Columns: Metric · BHFAN · BHFAM
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E 0.7x 0.7x
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) -52.7% -52.7%
Earnings Growth (YoY) -34.0% -34.0%
TTM Revenue (USD) $5.81B $5.81B
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin 16.5% 16.5%
Operating Margin 18.4% 18.4%
Net Profit Margin 11.7% 11.7%
Return on Equity (ROE) 11.9% 11.9%
4. Balance Sheet & Cash Flow BHFAN
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $87.13 Book/Sh · 11.9% ROE $87.13 Book/Sh · 11.9% ROE
Dividend Yield 14.25% 13.51%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Insurance - Life Operator Insurance - Life Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHFAN (1) vs BHFAM (1)
Institutional Metric BHFAN BHFAM Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
0.7x 0.7x Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-52.7% -52.7% Higher Growth Tie
Operating Margin (TTM)
Profitability
18.4% 18.4% Higher Margin Tie
Net Profit Margin
Profitability
11.7% 11.7% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
11.9% 11.9% Higher ROE Tie
52-Week Range Position
Momentum
0% ($9–$14) 4% ($8–$13) Stronger Trend BHFAM
Beta / 30D Volatility
Risk Regime
0.36β · 16% Vol 0.47β · 22% Vol Lower Realized Risk BHFAN
Unified Institutional Score
Composite Signal
33.7 / 100 (SELL) 33.6 / 100 (SELL) Higher Composite Tie
Trailing 12M Revenue (USD)
Operating Scale
$5.81B $5.81B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
16.5% 16.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($87.13 Book/Sh · 11.9% ROE) N/A ($87.13 Book/Sh · 11.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BHFAM +4.46 pp
BHFAN: -12.24% · BHFAM: -7.78%
3M Horizon BHFAM +5.86 pp
BHFAN: -21.4% · BHFAM: -15.54%
6M Horizon BHFAM +3.97 pp
BHFAN: -26.85% · BHFAM: -22.88%
1Y Horizon BHFAM +4.15 pp
BHFAN: -29.0% · BHFAM: -24.85%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHFAN vs BHFAM. Trailing 12-month operating profitability (BHFAN 18.4% vs BHFAM 18.4%) and valuation multiples (BHFAN N/M vs BHFAM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BHFAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.81B
Gross Margin16.5%
Op. Margin18.4%
ROE / Fwd P/E11.9% · N/M
BHFAM ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.81B
Gross Margin16.5%
Op. Margin18.4%
ROE / Fwd P/E11.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHFAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHFAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BHFAM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHFAM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHFAN Moat Profile Scale & Operating Efficiency Moat
Insurance - Life Operator
Competes within the Insurance - Life value chain with N/A market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
BHFAM Moat Profile Scale & Operating Efficiency Moat
Insurance - Life Operator
Competes within the Insurance - Life value chain with N/A market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BHFAN vs BHFAM Key Questions & Quantitative Answers

As of Nov 20, 2026, Brighthouse Financial, Inc. Depositary shares each representing a 1/1,000th Interest in a Share of 4.625% Non-Cumulative Preferred Stock, Series D (BHFAM) captures the overall head-to-head institutional edge over Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) on higher Unified Composite conviction (33.6/100 SELL vs. 33.7/100 SELL) after splitting the core matrix 1–1 (led by composite factor balance), while BHFAN wins 1–0 across the 6-pillar growth and valuation breakdown. BHFAN trades at $9.18 (N/M Forward P/E, 18.4% operating margin) versus BHFAM at $8.53 (N/M Forward P/E, 18.4% operating margin). Growth vs. Quality Trade-Off: BHFAM earns the overall head-to-head edge with a stronger Unified Composite Score (33.6/100 SELL vs. BHFAN 33.7/100 SELL) and 0.47β · 22% Vol risk profile, whereas BHFAN leads top-line expansion (-52.7% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although BHFAM compares more favorably head-to-head, both BHFAN (33.7/100 SELL) and BHFAM (33.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: BHFAN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9); meanwhile BHFAM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BHFAN and BHFAM split Growth & Scale metrics: BHFAN posts -52.7% YoY revenue growth and -34.0% YoY earnings growth on $5.81B TTM revenue (16.5% gross margin, 18.4% operating margin), compared with BHFAM at -52.7% YoY revenue growth and -34.0% YoY earnings growth on $5.81B TTM revenue (16.5% gross margin, 18.4% operating margin). On trailing 12-month operating scale, BHFAN generates $5.81B in USD-normalized revenue versus $5.81B for BHFAM. In operating R&D and SG&A reinvestment, BHFAN deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BHFAM.

BHFAN and BHFAM trade at balanced relative valuation multiples. BHFAN trades at N/M Forward P/E, 0.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BHFAM trades at N/M Forward P/E, 0.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHFAN (11.9% ROE) versus BHFAM (11.9% ROE) capital efficiency.

In options market volatility and institutional positioning, BHFAN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.36β · 16% Vol realized risk). By comparison, BHFAM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.47β · 22% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) Research Suite

Brighthouse Financial, Inc. Depositary shares each representing a 1/1,000th Interest in a Share of 4.625% Non-Cumulative Preferred Stock, Series D (BHFAM) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.